Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Doximity (DOCS) Shares Issued (2020 - 2025)

Doximity (DOCS) has disclosed Shares Issued for 6 consecutive years, with -$3.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Shares Issued fell 123.87% to -$3.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $7.6 million, a 69.79% decrease, with the full-year FY2025 number at $19.7 million, up 53.06% from a year prior.
  • Shares Issued was -$3.0 million for Q4 2025 at Doximity, down from $2.4 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $551.2 million in Q3 2021 to a low of -$5.7 million in Q4 2023.
  • A 5-year average of $33.0 million and a median of $2.6 million in 2022 define the central range for Shares Issued.
  • Peak YoY movement for Shares Issued: tumbled 405.93% in 2023, then surged 361.27% in 2024.
  • Doximity's Shares Issued stood at $551.2 million in 2021, then plummeted by 99.66% to $1.9 million in 2022, then crashed by 405.93% to -$5.7 million in 2023, then skyrocketed by 318.08% to $12.5 million in 2024, then tumbled by 123.87% to -$3.0 million in 2025.
  • Per Business Quant, the three most recent readings for DOCS's Shares Issued are -$3.0 million (Q4 2025), $2.4 million (Q3 2025), and $2.4 million (Q2 2025).